Skip to main content
Paul Goepfert, MD, Infectious Disease, Birmingham, AL, Birmingham Veterans Affairs Medical Center

PaulAGoepfertMD

Infectious Disease Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Dr. Goepfert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goepfert's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Infectious Disease, 1994 - 1997
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 1991 - 1994
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1991

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1992 - 2023
  • TX State Medical License
    TX State Medical License 1992 - 1997
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • HIV Vaccine Design Should Adapt as HIV Mutates
    HIV Vaccine Design Should Adapt as HIV MutatesMay 16th, 2016
  • GeoVax Announces Further Positive Results of Its HIV Preventive Vaccine Program at International HIV Research Conference
    GeoVax Announces Further Positive Results of Its HIV Preventive Vaccine Program at International HIV Research ConferenceOctober 24th, 2018
  • Pneumonia Vaccine Said to Reduce U.S. Hospitalizations
    Pneumonia Vaccine Said to Reduce U.S. HospitalizationsJuly 10th, 2013
  • Join now to see all

Grant Support

  • CTL And HIV Polymorphisms In Heterosexual TransmissionNational Institute Of Allergy And Infectious Diseases2010–2012
  • HIV-1 Cryptic Epitopes: Implications For Vaccine DesignNational Institute Of Allergy And Infectious Diseases2009–2011
  • ClinicalNational Institute Of Allergy And Infectious Diseases2008–2011
  • HIV-1 Suppression By MHC Class I Restricted CD8 T CellsNational Institute Of Allergy And Infectious Diseases2007–2008
  • Alabama/Zambia HIV Vaccine Clinical Trials Unit (HVTU)National Institute Of Allergy And Infectious Diseases2004–2006
  • CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2002–2005
  • CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2001
  • Human Foamy Virus Structural ProteinsNational Institute Of Allergy And Infectious Diseases1996–2000

Hospital Affiliations